Eric D. Shaff Seres Therapeutics, Inc. (MCRB) insider trading activity
Eric D. Shaff is CEO and President of Seres Therapeutics, Inc.. Currently has a direct ownership of 140,698 shares of MCRB, which is worth approximately $105,523. The most recent transaction as insider was on May 15, 2024, when has been sold 2,435 shares (Common Stock) at a price of $0.94 per share, resulting in proceeds of $2,288. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
141K
3.97%
3M change
46.05%
12M change
Total Value Held
$105,523
Eric D. Shaff Transaction History
Also insider at
EDS
Eric D. Shaff
CEO and President
Cambridge, MA